A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 618 participants.
Also called NCT07295418
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 618 participants
- Registry
-
NCT07295418
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07295418. Randomized; quadruple masking; primary purpose treatment. Start 2023-10-23 (actual); primary completion 2025-04-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia
- Condition
- Hyperlipidemias
- Intervention (Drug)
- SAL003 140 mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Collaborator
- Salubris (Chengdu) Biotechnology Co., Ltd.
Record details
- Record id
cardio:ct-nct07295418- Content hash
d7da155225fff9a2e43bae6d1e9e15a367a9239ef9da0e111a27f1ac7144046c